Get notified when DBVT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Dilution Per Ads to New Investors Purchasing In This Offering $3.86 (new) — New investors face immediate dilution of $3.86 per ADS, representing a significant portion of the assumed offering price.
  • Warrants and Pre-funded Warrants Issued In April 2025, Representing 254,923,061 Ordinary Shares, or Up to 50,984,612 Adss, Upon Exercise (new) — A large warrant overhang could cause substantial additional dilution if exercised.
  • We Believe That We May Have Been a Pfic During the Taxable Year Ended December 31, 2024 (new) — PFIC status could lead to adverse U.S. tax consequences for investors.
NASDAQ: DBVT DBV Technologies S.A. 424B5

DBV Technologies launches at-the-market offering of ADSs up to $150 million at $9.18 per ADS

Filed September 5, 2025 · ~2 min read

Key Changes

  • high

    DBV Technologies is offering ADSs (each representing five ordinary shares) with an aggregate offering price of up to $150 million. The offering is at-the-market, with no minimum amount required.

    The Offering verify on EDGAR →
  • medium

    The last reported sale price of the ADSs on Nasdaq was $9.18 per ADS on September 2, 2025. The offering price is not fixed; actual sales may occur at varying prices.

    The Offering verify on EDGAR →
  • medium

    Net proceeds are earmarked primarily for activities associated with the BLA, potential approval and launch of Viaskin Peanut patch in toddlers aged 1-3 years, as well as to advance development of product candidates using the Viaskin platform, and for working capital and general corporate purposes.

    Use of Proceeds verify on EDGAR →

4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MRSH 10-Q) is open in full — no account needed.

Partner

Trade DBVT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify